NASDAQ:MANH - Manhattan Associates Stock Price, News, & Analysis

Manhattan Associates trades on the NASDAQ under the ticker symbol "MANH."

Manhattan Associates declared that its board has authorized a stock buyback plan on Wednesday, February 7th 2018, which authorizes the company to buyback $50,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board believes its shares are undervalued.

Manhattan Associates, Inc. (NASDAQ:MANH) issued its quarterly earnings data on Tuesday, February, 5th. The software maker reported $0.46 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.37 by $0.09. The software maker had revenue of $144.37 million for the quarter, compared to the consensus estimate of $139.19 million. Manhattan Associates had a return on equity of 74.34% and a net margin of 18.72%. Manhattan Associates's revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 earnings per share. View Manhattan Associates' Earnings History.

Manhattan Associates is scheduled to release their next quarterly earnings announcement on Tuesday, April 23rd 2019. View Earnings Estimates for Manhattan Associates.

Manhattan Associates will be holding an earnings conference call on Tuesday, April 23rd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

Manhattan Associates issued an update on its FY19 earnings guidance on Tuesday, February, 5th. The company provided earnings per share guidance of $1.38-1.42 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.39. The company issued revenue guidance of $564-576 million, compared to the consensus revenue estimate of $564.22 million.Manhattan Associates also updated its FY 2019 guidance to $1.38-1.42 EPS.

2 brokers have issued twelve-month price targets for Manhattan Associates' stock. Their predictions range from $50.00 to $60.00. On average, they anticipate Manhattan Associates' stock price to reach $55.00 in the next year. This suggests that the stock has a possible downside of 4.0%. View Analyst Price Targets for Manhattan Associates.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Manhattan Associates in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Manhattan Associates.

Media headlines about MANH stock have trended positive this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Manhattan Associates earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave news stories about the software maker a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future.

Some companies that are related to Manhattan Associates include Citrix Systems (CTXS), PTC (PTC), Paycom Software (PAYC), Micro Focus International (MFGP), Atlassian (TEAM), The Ultimate Software Group (ULTI), Okta (OKTA), TAKE-TWO INTERACTIVE SOFTWARE (TTWO), Temenos (TMNSF), UBISOFT ENTMT S/ADR (UBSFY), Tableau Software (DATA), Docusign (DOCU), Dropbox (DBX), Tyler Technologies (TYL) and Guidewire Software (GWRE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Associates investors own include Aralez Pharmaceuticals (ARLZ), QUALCOMM (QCOM), Cisco Systems (CSCO), Gilead Sciences (GILD), Starbucks (SBUX), Skyworks Solutions (SWKS), Visa (V), Broadcom (AVGO), Biogen (BIIB) and Boeing (BA).

Manhattan Associates' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BTIM Corp. (0.89%), Retirement Systems of Alabama (0.38%), Denali Advisors LLC (0.27%), Denali Advisors LLC (0.25%), Capital Insight Partners LLC (0.03%) and Sciencast Management LP (0.02%). Company insiders that own Manhattan Associates stock include Bruce Richards, Dennis B Story, Eddie Capel, Edmond Eger, John J Huntz Jr and Robert G Howell. View Institutional Ownership Trends for Manhattan Associates.

MANH stock was sold by a variety of institutional investors in the last quarter, including Denali Advisors LLC, Denali Advisors LLC, State of Alaska Department of Revenue and First Hawaiian Bank. Company insiders that have sold Manhattan Associates company stock in the last year include Bruce Richards, Dennis B Story, Edmond Eger, John J Huntz Jr and Robert G Howell. View Insider Buying and Selling for Manhattan Associates.

MANH stock was bought by a variety of institutional investors in the last quarter, including BTIM Corp., Retirement Systems of Alabama, Sciencast Management LP, Strs Ohio, Nisa Investment Advisors LLC and Capital Insight Partners LLC. View Insider Buying and Selling for Manhattan Associates.

Shares of MANH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MANH stock can currently be purchased for approximately $57.30.

Manhattan Associates has a market capitalization of $3.70 billion and generates $559.16 million in revenue each year. The software maker earns $104.69 million in net income (profit) each year or $1.58 on an earnings per share basis. Manhattan Associates employs 3,000 workers across the globe.

The official website for Manhattan Associates is http://www.manh.com.

Manhattan Associates' mailing address is 2300 WINDY RIDGE PARKWAY TENTH FLOOR, ATLANTA GA, 30339. The software maker can be reached via phone at 770-955-7070 or via email at [email protected]